Atlas Trials

Safety and Efficacy of Inhaled Pre-prandial Human Insulin in Type 2 Diabetes

Clinical trial NCT00343980 · TERMINATED

Trial details

NCT number
NCT00343980
Sponsor
Novo Nordisk A/S
Status
TERMINATED
Phase
Phase 3
Study type
INTERVENTIONAL
DiabetesDiabetes Mellitus, Type 2
Start date
2006-10-10
Primary completion
2008-03-10
Enrollment
363

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.